The Group’s core purpose is to enhance the quality of life. Its vision is to be the partner of choice that people trust for all their healthcare needs.
The Company’s primary listing is on the London Stock Exchange ('LSE') in the United Kingdom ('UK'), with secondary listings on the JSE in South Africa and the Namibian Stock Exchange in Namibia. Mediclinic also holds a 29.7% interest in Spire Healthcare Group plc, a leading private healthcare group based in the UK and listed on the LSE.